Day: 23 November 2020

Will IPRs restrict access to Covid Vaccine?

November 23, 2020

The IPR waiver would allow all countries to choose to neither grant nor enforce patents and other IPRs related to COVID-19 drugs, vaccines, diagnostics and other technologies for the duration of the pandemic until global herd immunity is achieved. This move harkens back 20 years to the HIV/AIDS epidemic, when affordable generic HIV drugs, made in countries where patents did not block production, began saving millions of people’s lives.

Read More